Page 20 of 25

PA20.1-2 | DIC & Vitamin K Deficiency — Part 3

Vitamin K: Role and the Carboxylation Mechanism

A four-panel diagram explains vitamin K-dependent gamma-carboxylation, vitamin K recycling, warfarin inhibition, calcium-mediated membrane binding, and the affected coagulation proteins. — **Panel A:** Gamma-glutamyl carboxylase, Vitamin K KH2, Glu residues, Gla residues, Vitamin K epoxide, Ca2+, phospholipid surface, mature vitamin K-dependent coagulation factor. **Panel B:** Vitamin K epoxide, VKORC1 vitamin K epoxide reductase, Vitamin K quinone, Vitamin K KH2 active cofactor, Warfarin inhibition. **Panel C:** Carboxylated active factor, Gla domain, Ca2+ bridge, phospholipid membrane, tenase / prothrombinase assembly, uncarboxylated PIVKA, functionally inert factor. **Panel D:** Factors II prothrombin, VII, IX, X, anticoagulant proteins C and S, deficiency or warfarin bleeding tendency, newborn risk callout.

Vitamin K (a fat-soluble vitamin, including K1 from leafy vegetables and K2 from intestinal bacteria) is essential for the post-translational γ-carboxylation of glutamate residues on the vitamin K-dependent coagulation factors.

Vitamin K-dependent clotting factors: II (prothrombin), VII, IX, X (the "2, 7, 9, 10" mnemonic). Additionally, the anticoagulant proteins C and S are vitamin K-dependent.

The carboxylation mechanism:
1. Reduced vitamin K (KH₂) acts as co-factor for the enzyme γ-glutamyl carboxylase.
2. Carboxylation of specific glutamate residues creates γ-carboxyglutamate (Gla) residues.
3. Gla residues chelate Ca²⁺, enabling the coagulation factors to bind to phospholipid surfaces (the "tenase" and "prothrombinase" complexes).
4. Without Gla residues, factors II, VII, IX, and X are secreted as PIVKAs (Proteins Induced by Vitamin K Absence or Antagonism) — structurally complete but functionally inert.

Warfarin (coumarin anticoagulants) acts by blocking vitamin K epoxide reductase (VKORC1), preventing recycling of vitamin K epoxide back to active vitamin KH₂ — functionally equivalent to vitamin K deficiency.

Causes and Clinical Settings of Vitamin K Deficiency

Infographic showing neonatal, malabsorptive, antibiotic-related, warfarin-related, and liver disease causes of vitamin K deficiency converging on impaired clotting factor production and bleeding. — **Panel A:** Central vitamin K pathway: vitamin K, liver, gamma-carboxylation, factors II, VII, IX, X, Protein C, Protein S, normal haemostasis. **Panel B:** Haemorrhagic disease of newborn / VKDB: immature liver, sterile gut, low placental transfer, breast milk low in vitamin K, day 2-7 bleeding, late intracranial haemorrhage, IM vitamin K prophylaxis. **Panel C:** Malabsorption states: bile salts, jejunum/ileum absorption, cholestatic jaundice, bile duct obstruction, primary biliary cholangitis, coeliac disease, Crohn disease, short bowel syndrome, cystic fibrosis. **Panel D:** Antibiotic therapy: broad-spectrum antibiotics, third-generation cephalosporins, fluoroquinolones, reduced gut flora, reduced K2 production, poor oral intake. **Panel E:** Warfarin and coumarins: pharmacological vitamin K antagonism, blocked vitamin K recycling, supratherapeutic anticoagulation, haemorrhage. **Panel F:** Liver disease: reduced clotting factor synthesis, reduced clearance of activated factors, hypersplenism, thrombocytopenia, complex coagulopathy, partial response to vitamin K.

Vitamin K deficiency arises in several well-defined clinical scenarios:

1. Haemorrhagic disease of the newborn (HDN) — Vitamin K deficiency bleeding (VKDB)
Neonates have:
• Immature liver (limited synthesis of factors)
• Sterile gut at birth (no K2-producing flora)
• Low placental transfer of vitamin K
• Breast milk is a poor vitamin K source (formula is supplemented)
→ Classic HDN: presents day 2-7 of life (umbilical stump, gastrointestinal, circumcision bleeding)
→ Late HDN: weeks 2-12, intracranial haemorrhage — preventable with routine IM vitamin K at birth

2. Malabsorption states
Vitamin K is fat-soluble — absorption requires bile salts and healthy jejunum/ileum.
• Cholestatic jaundice (bile duct obstruction, primary biliary cholangitis)
• Coeliac disease, Crohn's disease, short bowel syndrome
• Cystic fibrosis (exocrine pancreatic insufficiency)

3. Antibiotic therapy
Broad-spectrum antibiotics (especially 3rd-generation cephalosporins, fluoroquinolones) sterilise gut flora → reduced K2 production. Clinically significant mainly when combined with poor oral intake.

4. Warfarin and coumarin anticoagulants
Intentional pharmacological vitamin K deficiency; supratherapeutic dose → haemorrhage.

5. Liver disease
Note: liver disease produces a complex coagulopathy (reduced synthesis of all clotting factors + reduced clearance of activated factors + often thrombocytopenia from hypersplenism). Vitamin K supplementation partially corrects PT in liver disease only if there is also a nutritional/malabsorption component.

Laboratory Findings in Vitamin K Deficiency

Diagram showing that vitamin K deficiency first prolongs PT due to early Factor VII depletion, later prolongs aPTT, and preserves platelets, fibrinogen, D-dimer, and peripheral film compared with DIC. — **Panel A:** Liver synthesis, Vitamin K, gamma-carboxylation, Factor II, Factor VII, Factor IX, Factor X, shortest Factor VII half-life, extrinsic pathway, PT prolonged first. **Panel B:** PT increased first, aPTT increased later, normal platelet count, normal fibrinogen, normal D-dimer / FDPs, peripheral film without schistocytes. **Panel C:** Vitamin K deficiency versus DIC, intact platelets, normal fibrinogen, absent fibrin deposition, normal D-dimer, consumed platelets in DIC, fibrin strands, raised D-dimer, schistocytes.

The laboratory pattern of vitamin K deficiency is distinctive and must be contrasted with DIC:

Test	Vitamin K deficiency	Reason
PT	↑↑ (prolonged first)	Factor VII has the shortest half-life (~4-6 hours) → depletes fastest → PT (extrinsic pathway) prolongs before aPTT
aPTT	↑ (prolonged later)	Factors IX and X eventually depleted → intrinsic pathway affected
Platelet count	Normal	Platelets are NOT vitamin K-dependent
Fibrinogen	Normal	Fibrinogen synthesis is independent of vitamin K
D-dimer / FDPs	Normal	No systemic fibrin deposition or secondary fibrinolysis
Peripheral film	Normal	No schistocytes (no microangiopathy)

Key teaching point: The PT-first, aPTT-second prolongation pattern with normal platelets and normal fibrinogen is the hallmark of vitamin K deficiency (or warfarin). This contrasts sharply with DIC where both PT and aPTT are prolonged AND platelets and fibrinogen are low AND D-dimer is markedly elevated.

Correction test: A parenteral vitamin K dose (10 mg IV/IM) corrects PT within 6-24 hours in vitamin K deficiency. Failure to correct suggests liver disease as the dominant cause (hepatic failure cannot respond to vitamin K — there are no functional hepatocytes to synthesise factors).

SELF-CHECK

Why does the PT prolong BEFORE the aPTT in vitamin K deficiency?

A. Vitamin K preferentially carboxylates factor VIII, which is measured by PT

B. The intrinsic pathway has redundant bypass mechanisms that compensate initially

C. Vitamin K is absorbed preferentially by hepatocytes that synthesise intrinsic pathway factors

D. Factor VII, which is measured exclusively by the PT (extrinsic pathway), has the shortest plasma half-life among vitamin K-dependent factors

Reveal Answer

Answer: D. Factor VII, which is measured exclusively by the PT (extrinsic pathway), has the shortest plasma half-life among vitamin K-dependent factors

Factor VII has a plasma half-life of only 4-6 hours — the shortest of all vitamin K-dependent coagulation factors (compare: factor IX ~24 h, factor X ~36-48 h, prothrombin [II] ~60-72 h). When vitamin K is depleted or antagonised, factor VII levels fall first. Since the PT (prothrombin time) assays the extrinsic pathway which begins with the tissue factor–factor VII complex, PT prolongs before aPTT. This is why PT is more sensitive than aPTT as an early indicator of vitamin K deficiency or warfarin effect.